Mapping of HPV transcripts in four human cervical lesions using RNAseq suggests quantitative rearrangements during carcinogenic progression

Autor: Chen, Jinmiao, Xue, Yuezhen, Poidinger, Michael, Lim, Thimothy, Chew, Sung Hock, Pang, Chai Ling, Abastado, Jean-Pierre, Thierry, Françoise

Publikováno v: In Virology August 2014 462-463:14-24

Genome-wide analysis of high risk human papillomavirus E2 proteins in human primary keratinocytes

Autor: Sunthamala, Nuchsupha, Pang, Chai Ling, Thierry, Francoise, Teissier, Sebastien, Pientong, Chamsai, Ekalaksananan, Tipaya

Publikováno v: In Genomics Data December 2014 2:147-149

SAIL66, a next generation CLDN6-targeting T-cell engager, demonstrates potent antitumor efficacy through dual binding to CD3/CD137.

Autor: Kamikawa T; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan., Kimura N; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan kimuranok@chugai-pharm.co.jp., Ishii S; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan., Muraoka M; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan., Kodama T; Chugai Pharmaceutical Co Ltd, Chuo-ku, Tokyo, Japan., Taniguchi K; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan., Yoshimoto M; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan., Miura-Okuda M; Chugai Pharmaceutical Co Ltd, Kita-ku, Tokyo, Japan., Uchikawa R; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan., Kato C; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan., Shinozuka J; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan., Akai S; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan., Naoi S; Chugai Pharmabody Research Pte Ltd, Singapore., Tomioka N; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan., Nagaya N; Chugai Pharmabody Research Pte Ltd, Singapore., Pang CL; Chugai Pharmabody Research Pte Ltd, Singapore., Garvita G; Chugai Pharmabody Research Pte Ltd, Singapore., Feng S; Chugai Pharmabody Research Pte Ltd, Singapore., Shimada M; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan., Kamata-Sakurai M; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan., Aburatani H; The University of Tokyo, Bunkyo-ku, Japan., Kitazawa T; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan., Igawa T; Chugai Pharmaceutical Co Ltd, Yokohama, Kanagawa, Japan.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Oct 14; Vol. 12 (10). Date of Electronic Publication: 2024 Oct 14.